Aravive, Inc. (ARAV): Price and Financial Metrics
ARAV Price/Volume Stats
| Current price | $0.04 | 52-week high | $2.46 |
| Prev. close | $0.05 | 52-week low | $0.04 |
| Day low | $0.04 | Volume | 4,040,000 |
| Day high | $0.05 | Avg. volume | 4,251,645 |
| 50-day MA | $0.12 | Dividend yield | N/A |
| 200-day MA | $0.70 | Market Cap | 2.95M |
ARAV Stock Price Chart Interactive Chart >
Aravive, Inc. (ARAV) Company Bio
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases. Its lead product candidate is AVB-500, a decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase Ib/II clinical trial for the treatment of platinum- resistant recurrent ovarian cancer, as well as for the treatment of clear cell renal cell carcinoma, triple negative breast cancer, acute myeloid leukemia, and pancreatic cancer. The company has a strategic collaboration agreement with WuXi Biologics to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. is headquartered in Houston, Texas.
ARAV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -68.58% |
| 3-year | -98.47% |
| 5-year | -99.67% |
| YTD | -67.66% |
| 2023 | -90.63% |
| 2022 | -39.73% |
| 2021 | -61.17% |
| 2020 | -58.74% |
| 2019 | 288.35% |
Continue Researching ARAV
Want to see what other sources are saying about Aravive Inc's financials and stock price? Try the links below:Aravive Inc (ARAV) Stock Price | Nasdaq
Aravive Inc (ARAV) Stock Quote, History and News - Yahoo Finance
Aravive Inc (ARAV) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...